 REDWOOD CITY, Calif., April 5, 2021 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that results of its SENZA-PDN randomized clinical trial RCT were published online in JAMA Neurology. 